The independent source for health policy research, polling, and news.
901 - 920 of 1,299 Results
Congress approved two bills last month that prohibit provisions keeping pharmacists from telling patients when they can save money by paying the cash price instead of the price negotiated by their insurance plan.
Addiction experts argue that buprenorphine, which drug users buy on the street, actually saves lives because it is used in place of more dangerous substances, like heroin and fentanyl.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
Health insurers and pharmacy benefit managers are exploring how two legal provisions which have been on the books for decades could bring down the price tags of certain prescription medications.
In the bipartisan opioid bill headed to the presidents desk, hospice workers would be allowed to destroy patients unneeded opioids, reducing the risk that families misuse them.
In this episode of KHNs What the Health? Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner discuss final action on bills in Congress to address the opioid epidemic and fund federal health agencies. They also look at new efforts by the Food and Drug Administration to crack down on teen nicotine use.
A project that started in a Boston Veterans Affairs facility will soon go nationwide. It puts naloxone, also known as Narcan, into emergency supplies cabinets throughout the VA system.
Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now theres a twist involving an opioid treatment.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
In this episode of KHNs What the Health? Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Ollstein of Politico talk about how health issues will play in midterm elections, the Trump administrations move that could penalize legal immigrants who use government aid programs, and other topics. Due to technical difficulties, the original discussion taped Sept. 27 at the 2018 Texas Tribune Festival could not be broadcast, so the panelists reconvened from Austin and Washington on Sept. 28.
The protection is a win for people who get their needed, legitimate drugs from overseas.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Despite the growing epidemic of Americans misusing opioids and overdosing on the job, many employers turn a blind eye to addiction within their workforce ill-equipped or unwilling to confront an issue they are at a loss to handle.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
Medicaid drug spending doubled in five years in Massachusetts. The state wanted to exclude expensive drugs that weren't proven to work better than existing alternatives from its Medicaid plan, but the federal government blocked the effort.
Federal officials are allowing the private insurance plans to use step therapy for drugs administered by doctors. In step therapy, patients must first use cheaper drugs to see if they work before receiving more expensive options.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you dont have to.
穢 2026 KFF